Predictors of exacerbations of asthma and COPD during one year in primary care

Family Practice

Volumn 30, Issue 6, 2013, Pages 621-628

  Al Ani, Salwan ^a   Spigt, Mark ^a,b   Hofset, Per ^c   Melbye, Hasse ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c Skedsmokorset Clinic   (Norway)

Author keywords

Asthma; COPD; Exacerbation; Primary care

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID;

ADULT; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EXAMINATION; DISEASE EXACERBATION; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENERAL CONDITION DETERIORATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIMARY MEDICAL CARE;

ASTHMA; COPD; EXACERBATION; PRIMARY CARE.;

ADULT; AGED; ASTHMA; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; NORWAY; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; RISK FACTORS; VITAL CAPACITY;

EID: 84888182817     PISSN: 02632136     EISSN: 14602229     Source Type: Journal    
DOI: 10.1093/fampra/cmt055     Document Type: Article

References (30)

1. Rabe KF, Hurd S, Anzueto A et al. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532-55.
2. Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157(5 Pt 1): 1418-22.
3. Anzueto A. Primary care management of chronic obstructive pulmonary disease to reduce exacerbations and their consequences. Am J Med Sci 2010; 340: 309-18.
4. The Global Initiative for Asthma. http://www.ginasthma.org. 2012.
5. Guerra S. Overlap of asthma and chronic obstructive pulmonary disease. Curr Opin Pulm Med 2005; 11: 7-13.
6. Alrawi YA, Potter JF, Myint PK. UK National COPD Resources and Outcomes Project (NCROP): 2008 National audit data presents an opportunity to highlight the areas for improvement in COPD care in the ageing population. COPD 2010; 7: 360-5.
7. O'Reilly JF, Williams AE, Holt K, Rice L. Defining COPD exacerbations: impact on estimation of incidence and burden in primary care. Prim Care Respir J 2006; 15: 346-53.
8. Donaldson GC, Hurst JR, Smith CJ, Hubbard RB, Wedzicha JA. Increased risk of myocardial infarction and stroke following exacerbation of COPD. Chest 2010; 137: 1091-7.
9. Soler-Cataluña JJ, Martínez-García MA, Román Sánchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005; 60: 925-31.
10. Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002; 57: 847-52.
11. Hurst JR, Vestbo J, Anzueto A et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010; 363: 1128-38.
12. Reddel HK, Taylor DR, Bateman ED et al. American Thoracic Society/ European Respiratory Society Task Force on Asthma Control and Exacerbations. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009; 180: 59-99.
13. Ortega H, Miller DP, Li H. Characterization of asthma exacerbations in primary care using cluster analysis. J Asthma 2012; 49: 158-69.
14. Tomita K, Sano H, Iwanaga T et al. Association between episodes of upper respiratory infection and exacerbations in adult patients with asthma. J Asthma 2012; 49: 253-9.
15. Miller MK, Lee JH, Miller DP, Wenzel SE; TENOR Study Group. Recent asthma exacerbations: a key predictor of future exacerbations. Respir Med 2007; 101: 481-9.
16. Melbye H, Drivenes E, Dalbak LG, Leinan T, Høegh-Henrichsen S, Ostrem A. Asthma, chronic obstructive pulmonary disease, or both? Diagnostic labeling and spirometry in primary care patients aged 40 years or more. Int J Chron Obstruct Pulmon Dis 2011; 6: 597-603.
17. Ställberg B, Nokela M, Ehrs PO, Hjemdal P, Jonsson EW. Validation of the clinical COPD Questionnaire (CCQ) in primary care. Health Qual Life Outcomes 2009; 7: 26.
18. Miller MR, Hankinson J, Brusasco V et al. ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J 2005; 26: 319-38.
19. Piras B, Miravitlles M. The overlap phenotype: the (missing) link between asthma and COPD. Multidiscip Respir Med 2012; 7: 8.
20. Hoogendoorn M, Feenstra TL, Schermer TR, Hesselink AE, Rutten-van Mölken MP. Severity distribution of chronic obstructive pulmonary disease (COPD) in Dutch general practice. Respir Med 2006; 100: 83-6.
21. Izquierdo JL, Martín A, de Lucas P, Rodríguez-González-Moro JM, Almonacid C, Paravisini A. Misdiagnosis of patients receiving inhaled therapies in primary care. Int J Chron Obstruct Pulmon Dis 2010; 5: 241-9.
22. Miravitlles M, Soler-Cataluña JJ, Calle M, Soriano JB. Treatment of COPD by clinical phenotypes: putting old evidence into clinical practice. Eur Respir J 2013; 41: 1252-6.
23. Haugen T, Bakken IJ, Storrø O, Øien T, Langhammer A. Development of diagnostic labeling and health services utilization in patients with obstructive lung diseases. Norw Med Assoc J 2008; 128: 2431-4.
24. Jia CE, Zhang HP, Lv Y et al. The Asthma Control Test and Asthma Control Questionnaire for assessing asthma control: Systematic review and meta-analysis. J Allergy Clin Immunol 2013; 131: 695-703.
25. Wan ES, DeMeo DL, Hersh CP et al. Clinical predictors of frequent exacerbations in subjects with severe chronic obstructive pulmonary disease (COPD). Respir Med 2011; 105: 588-94.
26. Cote CG, Dordelly LJ, Celli BR. Impact of COPD exacerbations on patient-centered outcomes. Chest 2007; 131: 696-704.
27. Spencer S, Calverley PM, Burge PS, Jones PW. Impact of preventing exacerbations on deterioration of health status in COPD. Eur Respir J 2004; 23: 698-702.
28. Serra-Batlles J, Plaza V, Morejón E, Comella A, Brugués J. Costs of asthma according to the degree of severity. Eur Respir J 1998; 12: 1322-6.
29. Miller MK, Lee JH, Blanc PD et al. TENOR Study Group. TENOR risk score predicts healthcare in adults with severe or difficult-to-treat asthma. Eur Respir J 2006; 28: 1145-55.
30. Niewoehner DE. The impact of severe exacerbations on quality of life and the clinical course of chronic obstructive pulmonary disease. Am J Med 2006; 119(Suppl 1): 38-45.